Pharmacokinetic profile of SKP‐1041, a modified release formulation of zaleplon

@article{Greenblatt2011PharmacokineticPO,
  title={Pharmacokinetic profile of SKP‐1041, a modified release formulation of zaleplon},
  author={D. Greenblatt and J. Harmatz and James K. Walsh and R. Luthringer and L. Staner and S. Otmani and J. N{\'e}d{\'e}lec and C{\'e}line Francart and Sarah J. Parent and C. Staner},
  journal={Biopharmaceutics & Drug Disposition},
  year={2011},
  volume={32}
}
Two investigations aimed to define the pharmacokinetic profile of a modified‐release preparation of zaleplon (SKP‐1041). 
3 Citations

References

SHOWING 1-10 OF 37 REFERENCES
Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo
  • 108
Zaleplon pharmacokinetics and absolute bioavailability.
  • 76
Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
  • 172
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
  • 90
...
1
2
3
4
...